Intelligent Bio Solutions

Intelligent Bio Solutions Financing Cash Flow

The Net Financing Cash Flow of Intelligent Bio Solutions (INBS) as of Oct 21, 2026 is 14.98 M USD. In the previous year, Net Financing Cash Flow was 4.60 M USD — a change of 225.89% (higher).

Financing Cash Flow

14.98 MUSD

YoY

225.89%

Last updated:

Net Financing Cash Flow of Intelligent Bio Solutions is 2026 14.98 M USD. Net Financing Cash Flow of Intelligent Bio Solutions was 2025 4.60 M USD. It decreases by 225.89% higher compared to the previous year.

The Intelligent Bio Solutions Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2019
5.32 M USD
Jan 1, 2020
733,862.00 USD
Jan 1, 2021
23.40 M USD
Jan 1, 2022
1.44 M USD
Jan 1, 2023
1.44 M USD
Jan 1, 2024
14.56 M USD
Jan 1, 2025
4.60 M USD
Jan 1, 2026
14.98 M USD
The Intelligent Bio Solutions Financing Cash Flow history
YEARFinancing Cash FlowYoY
14.98 MUSD+225.89%
4.60 MUSD-68.42%
14.56 MUSD+914.44%
1.44 MUSD0.00%
1.44 MUSD-93.87%
23.40 MUSD+3,089.01%
733,862.00USD-86.20%
5.32 MUSD+2.71%
5.18 MUSD+1,626.67%
299,921.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligent Bio Solutions stock

Net Financing Cash Flow of Intelligent Bio Solutions is 14.98 M USD in 2026.

Net Financing Cash Flow of Intelligent Bio Solutions changed from 4.60 M USD to 14.98 M USD, representing a 225.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Intelligent Bio Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions